Periprocedural Diabetic Ketoacidosis (DKA) with SGLT2 Inhibitor Use In People with Diabetes (May 2023)
Summary The ADS together with ADEA and ANZCA have made an update to the Alert – ‘Periprocedural Diabetic Ketoacidosis (DKA) with SGLT2 Inhibitor use in People with Diabetes’ incorporating recently published